Neuronex gets US FDA GLP certification

Local biopharmaceutical firm Neuronex Co. has recently passed the GLP (Good Laboratory Practice) skin irritation test of the US Food and Drug Administration over its new topical treatment for Raynaud's disease, according to a company spokesperson.

Neuronex has developed a novel, peripheral blood vessel vasodilation system called “BV 2.”

BV 2 is a major breakthrough in peripheral blood cir...